| Serial Number | 88424859 |
| Word Mark | CERECOR |
| Filing Date | Friday, May 10, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, July 4, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 8, 2019 |
| Description of Mark | The mark consists of a crescent shaped figure with various lines throughout and the word "CERECOR" written within the crescent with the points of the crescent falling on the "ER" of the word. |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of disorders and diseases in or affecting the central nervous system; Pharmaceutical preparations for the treatment of the brain, central nervous system, and psychiatric and neurological diseases and disorders; Pharmaceutical preparations and substances for the prevention and treatment of major depressive disorder, mood disorder, psychosis, anxiety, epilepsy, sclerosis, porphyries, stroke, Huntington's disease, insomnia, Parkinson's disease, cognitive impairment; Pharmaceutical preparations for the treatment of ectoparasites, such as head lice; Steroids; Pharmaceutical preparations containing prednisolone for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system; Pharmaceutical preparations containing prednisolone for the treatment of inflammatory disorders; Pharmaceutical preparations containing prednisolone for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Medical delivery apparatus, namely, a valved holding chamber sold empty for use with metered dose inhalers; Cephalosporins; Antibiotics; Pharmaceutical preparations for the treatment of reflux, esophagitis, GERD (Gastro-Esophageal Reflux Disease), dyspepsia, heartburn, acid regurgitation, pyrosis, epigastric pain, irritative cough and dysphonia; Oral modified release, extended release, and/or sustained release pharmaceutical preparations for the drug carbinoxamine, a pharmaceutically acceptable salt thereof and/or carbinoxamine polistirex, intended for the treatment of seasonal and perennial allergic rhinitis, and other approved uses; Vitamin, mineral and fluoride preparations for human medical or nutritional uses; Nutritional preparation in the nature of nutritional supplement containing vitamins and fluoride; Pharmaceutical products and treatments for pediatric onset and rare and orphan disorders, namely, oral formulation of D-galactose for the treatment of phosphoglucomutase 1 (PGM1) deficiency (PGM1-CDG), oral formulation of D-mannose for the treatment of Mannose Phosphate Isomerase (MPI) deficiency (MPI-CDG), oral formulation of L-fucose for the treatment of Leukocyte Adhesion Deficiency Type II (LADII) (SLC35C1-CDG), nucleotide prodrug for the treatment of Deoxyguanosine Kinase (DGUOK) deficiency; Pharmaceutical products and treatments for pediatric onset and rare and orphan disorders, namely, oral formulations for the treatment of congenital disorders of glycosylation; Pharmaceutical products and treatments for pediatric onset and rare and orphan disorders, namely, oral nucleotide replacements for the treatment of Myelodysplastic Syndromes; Pharmaceutical preparations and substances for the treatment of neurogenic orthostatic hypotension (nOH) associated with neurodegenerative diseases such as Parkinson's Disease, Multiple Systems Atrophy, and Pure Autonomic Failure; Transmembrane AMPA receptor regulatory proteins (TARPs) for use as anticonvulsant agents and to modulate neurotransmission in patients with epilepsy; Oral neuro-selective adjunctive medications; Selective kappa opioid receptor (KOR) antagonist for the treatment of major depressive disorder (MDD) and for substance use disorders |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, May 25, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AVALO THERAPEUTICS, INC. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | WAYNE, PA 19087 |
| Party Name | Cerecor Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Englewood, CO 80112 |
| Party Name | Cerecor Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Rockville, MD 20850 |
| Event Date | Event Description |
| Tuesday, July 5, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, July 4, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, December 3, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 1, 2021 | SOU EXTENSION 4 GRANTED |
| Wednesday, December 1, 2021 | SOU EXTENSION 4 FILED |
| Wednesday, December 1, 2021 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, September 22, 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Saturday, May 22, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 20, 2021 | SOU EXTENSION 3 GRANTED |
| Thursday, May 20, 2021 | SOU EXTENSION 3 FILED |
| Thursday, May 20, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 8, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, December 7, 2020 | SOU EXTENSION 2 GRANTED |
| Wednesday, December 2, 2020 | SOU EXTENSION 2 FILED |
| Wednesday, December 2, 2020 | SOU TEAS EXTENSION RECEIVED |
| Friday, June 5, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, June 3, 2020 | SOU EXTENSION 1 GRANTED |
| Wednesday, June 3, 2020 | SOU EXTENSION 1 FILED |
| Wednesday, June 3, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 2, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, June 2, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, June 2, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, June 2, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, June 2, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, June 2, 2020 | WITHDRAWAL OF ATTORNEY GRANTED |
| Tuesday, June 2, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Wednesday, May 27, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, May 27, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, April 28, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, April 28, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 28, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, April 28, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, April 28, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, April 28, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, December 3, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 8, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 8, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 18, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, September 5, 2019 | ASSIGNED TO LIE |
| Tuesday, September 3, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 30, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 30, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 30, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 1, 2019 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Thursday, August 1, 2019 | PRIORITY ACTION E-MAILED |
| Thursday, August 1, 2019 | PRIORITY ACTION WRITTEN |
| Thursday, July 25, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, May 28, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, May 25, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 14, 2019 | NEW APPLICATION ENTERED |